Also, our finding that sPD-1 levels in controls are higher than in CCRCC patients could be explained by a confounding effect of disparity levels in CCRCC patients due to the fact that the sample includes patients with all stages of disease. Here, HOXD13 is linked to nonpapillary renal cell carcinoma.